Polish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Current Pharmaceutical Design 2019-Oct

Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver disease with High Mortality and Misdiagnosis Rate.

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły
Zaloguj się Zarejestruj się
Link zostanie zapisany w schowku
Pengcheng Ou
Xinyu Liu
Zhiqun Tang
Zhouhua Hou
Li Liu
Jun Liu
Shangchen Zhou
Zhixiong Fang
Kewei Sun
Yue Chen

Słowa kluczowe

Abstrakcyjny

Gynura segetum (Tusanqi or Jusanqi) is widely used in China and often causes hepatic sinusoidal obstruction syndrome (HSOS). However, its extent in inducing hepatotoxicity is not sufficiently understood. Therefore, we aimed to identify the features of the Gynura segetum related HSOS.A total of 64 patients diagnosed with HSOS induced by gynura segetum were recruited from eight Chinese tertiary care hospitals between 2008 and 2018. General information regarding diagnosis, disease history, suspected drug use, symptoms and signs, biochemical index, imaging data, liver histology, treatment methods, severity and prognosis were collected and analyzed.The mean age of the patients was 58.07±11.44 years. Male patients accounted for 64.1% of the HSOS patients. The median latency period was 75 days. The number of patients with definite diagnosis from the eight hospitals was 5 (7.81%), with a misdiagnosis rate of 92.18%. Hepatomegaly, splenomegaly, ascites and lower limbs edema were present in 89.1%, 76.6%, 81.3% and 43.8% of the patients, respectively. The imaging characteristic changes were liver parenchyma echo thickening, uneven density, and hepatic vein stenosis and occlusion. Liver biopsies presented characteristic pathological changes. Except for ALT and D-Dimer, liver function and coagulation index at admission and before discharge had no significant difference (p>0.05). The general 6-month mortality rate was 77.55%, with upper-gastrointestinal bleeding being the leading cause of death (42.11%); the second leading cause was secondary infection (36.84%), while the third was hepatorenal syndrome (21.05%).Gynura segetum related HSOS often presents as progressive hepatic congestion, portal hypertension and liver failure, simultaneously, with a high mortality and misdiagnosis rate.

Dołącz do naszej strony
na Facebooku

Najbardziej kompletna baza danych ziół leczniczych poparta naukowo

  • Działa w 55 językach
  • Ziołowe leki poparte nauką
  • Rozpoznawanie ziół na podstawie obrazu
  • Interaktywna mapa GPS - oznacz zioła na miejscu (wkrótce)
  • Przeczytaj publikacje naukowe związane z Twoim wyszukiwaniem
  • Szukaj ziół leczniczych po ich działaniu
  • Uporządkuj swoje zainteresowania i bądź na bieżąco z nowościami, badaniami klinicznymi i patentami

Wpisz objaw lub chorobę i przeczytaj o ziołach, które mogą pomóc, wpisz zioło i zobacz choroby i objawy, na które są stosowane.
* Wszystkie informacje oparte są na opublikowanych badaniach naukowych

Google Play badgeApp Store badge